| DIVBC | disseminated intravascular blood coagulation |
|---|---|
| DIVC | disseminated intravascular coagulation |
| FMFD | V familial multiple coagulation factor deficiency V |
| F2R | [blood coagulation] factor II receptor |
| ICF | immunodeficiency-centromeric instability-facial anomalies [syndrome]; indirect centrifugal flotation... |
| LACI | Lipoprotein Associated Coagulation Inhibitor |
|---|---|
| MCT | Microwave coagulation therapy |
| PMCT | Percutaneous microwave coagulation therapy |
| DIC | diffuse intravascular coagulation |
| light coagulation | The coagulation of tissue by an intense beam of light, including laser (laser coagulation). In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, haemorrhages, and malignant and benign neoplasms. (12 Dec 1998) |
|---|---|
| lipoprotein-associated coagulation inhibitor | Formerly known as anticonvertin; a protein that inhibits the extrinsic pathway of coagulation by binding to the tissue factor III-factor VII-Calcium-factor Xa complex. (05 Mar 2000) |
| lupus coagulation inhibitor | An antiphospholipid antibody found in association with systemic lupus erythematosus (lupus erythematosus, systemic), antiphospholipid syndrome, and in a variety of other diseases as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including foetal death and spontaneous abortion, as well as a variety of haematologic and neurologic complications. (12 Dec 1998) |